Inventiva Appoints Chris Benecchi as Chief Operating Officer
Inventiva (IVA) has named Chris Benecchi its new chief operating officer. In this role, he will oversee the company's operational readiness ahead of key developments in its pipeline. Benecchi is expected to play a critical part in preparing for the pivotal NATiV3 Phase 3 trial results for lanifibranor in MASH, which are anticipated in Q4 2026. This appointment comes as Inventiva builds momentum toward potential regulatory and commercial milestones.
Tickers: $IVA
Topics: Biotech Clinical Trials Leadership Change